Protein-losing enteropathy after the modified Fontan operation: Oral prednisone treatment with biopsy and laboratory proved improvement

T. M. Zellers, K. Brown

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

Protein-losing enteropathy occurs in up to 10% of patients following the modified Fontan procedure. Treatment is still controversial. We describe a female adolescent who developed protein-losing enteropathy 4 years after a modified Fontan procedure. Treatment with oral prednisone attenuated the protein loss with subsequent normalization of her serum total protein and albumin levels. Discontinuation of prednisone therapy was associated with relapse, which was again treated successfully with low-dose oral prednisone. Small bowel biopsy-proved diagnosis with improvement, relapse, and improvement again are documented, as are other useful laboratory findings.

Original languageEnglish (US)
Pages (from-to)115-117
Number of pages3
JournalPediatric Cardiology
Volume17
Issue number2
DOIs
StatePublished - Jan 1 1996

Keywords

  • Fontan operation
  • Prednisone
  • Protein-losing enteropathy
  • Small bowel biopsy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Protein-losing enteropathy after the modified Fontan operation: Oral prednisone treatment with biopsy and laboratory proved improvement'. Together they form a unique fingerprint.

  • Cite this